KLK3 and prostate cancer: In a meta-analysis of 18 long-term randomised clinical trials involving 2.1 million individuals, there was no compelling evidence that commonly used cancer screening tests—such as PSA testing for prostate cancer, mammography for breast cancer, and colonoscopy or faecal occult blood testing for colorectal cancer—prolong overall lifespan.33